Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective ...

KEEN to lose weight in 2025? So are almost half of our readers. While weight-loss jabs, similar to Ozempic, boomed in ...

Many viewers of the 2025 Golden Globes quickly noticed stars who seemed to have embraced GLP-1 medications that help people ...

A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, manufactured by Novo Nordisk. Reuters Eli Lilly said Wednesday that its obesity drug Zepbound ...

Metsera has linked its GLP-1 drug candidate to weight loss of up to 11.3% after 12 weeks, encouraging the biotech to use some ...

Over her three-decade career, weight management physician Dr. Sarah Ro has seen hundreds of patients. Many of them are on ...

With 13 states offering coverage, it’s already a $3.9 billion cost. Some state officials say reducing obesity will save programs money in the long run.

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 492.13% and ...

I had been taking Zepbound for about six months when it clicked. My period — the monster that turned me from a functioning ...

New tests may show how much value a particular obese patient will get for a GLP-1 agonist prescription dollar.

A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic.

As the weight-loss drugs become more popular, consumer habits are starting to reflect changing consumption behavior, ...